Julia Perttilä Selected Research

Julia Perttilä Research Topics

4	Insulin Resistance 01/2020 - 07/2011
3	Non-alcoholic Fatty Liver Disease 01/2016 - 12/2010
2	Inflammation (Inflammations) 12/2018 - 01/2016
2	Atherosclerosis 12/2018 - 01/2016
2	Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial) 01/2016 - 08/2009
1	Obesity 12/2018
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2016
1	Neoplasms (Cancer) 01/2016
1	Metabolic Diseases (Metabolic Disease) 01/2016
1	Hyperinsulinism (Hyperinsulinemia) 10/2015
1	Peripheral Arterial Disease 12/2012
1	Dyslipidemias (Dyslipidemia) 12/2012
1	Hepatocellular Carcinoma (Hepatoma) 05/2012
1	Lipodystrophy 07/2011
1	Liver Diseases (Liver Disease) 07/2011
1	Weight Loss (Weight Reduction) 07/2011
1	Fatty Liver 12/2010

5	Triglycerides (Triacylglycerol)IBA 12/2018 - 08/2009
3	Glycerol (Glycerine)FDA LinkGeneric 01/2020 - 12/2010
2	Messenger RNA (mRNA)IBA 01/2020 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2015
2	LipidsIBA 01/2016 - 12/2010
2	Insulin (Novolin)FDA Link 01/2016 - 10/2015
2	Phospholipases (Phospholipase)IBA 04/2014 - 07/2011
2	oxysterol binding proteinIBA 12/2012 - 08/2009
1	CholesterolIBA 12/2018
1	CytokinesIBA 12/2018
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	Protons (Proton)IBA 07/2011
1	Glucose (Dextrose)FDA LinkGeneric 07/2011
1	adiponutrinIBA 07/2011
1	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 12/2010
1	Nonesterified Fatty Acids (NEFA)IBA 12/2010
1	EndocannabinoidsIBA 12/2010
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2010
1	KetonesIBA 12/2010
1	HDL LipoproteinsIBA 08/2009

1	Therapeutics 07/2011
1	Highly Active Antiretroviral Therapy (HAART) 07/2011